3.2 Tear Film Dynamics, Dry Eye & Severe Ocular Surface Disease

3.2 Tear Film Dynamics, Dry Eye & Severe Ocular Surface Disease

The prefit evaluation of tear film dynamics is pivotal in specialty contact lens practice. The tear film serves not only as the primary refracting optical interface of the human eye (accounting for approximately +43.00 D of refractive power at the air-tear interface), but also as a biological lubricant, nutrient supply, and immunological barrier. A compromised tear film can transform an otherwise well-fitted specialty lens into an unwearable, sight-threatening hazard.

---

The Contemporary Tear Film Model

Historic teaching posited a strict three-layer model of the precorneal tear film (lipid, aqueous, and mucin layers; Wolff, 1946). Modern biochemical and biophysical research (TFOS DEWS II) has supplanted this with a two-layer model consisting of an anterior lipid layer overlying a continuous muco-aqueous gel phase:

1. Preocular Lipid Layer ($40\text{--}100\text{ nm}$):
   • Origin: Secreted primarily by the holocrine meibomian glands situated within the tarsal plates of the upper and lower eyelids.
   • Architecture: Subdivided into an outer non-polar lipid sublayer (cholesteryl esters, wax esters, triglycerides) that directly interfaces with air to retard tear evaporation and lower surface tension, and an inner polar lipid sublayer (phospholipids, sphingolipids, $\omega$-hydroxy fatty acids) that functions as an amphiphilic surfactant bridging the non-polar lipids with the aqueous phase.
2. Muco-Aqueous Gel Layer ($\sim 3\text{--}4\ \mu\text{m}$):
   • Origin: Secreted jointly by the main and accessory lacrimal glands (Krause and Wolfring) and conjunctival goblet cells.
   • Architecture: A hydrated gel exhibiting a continuous concentration gradient. Near the epithelial microplicae, large membrane-associated transmembrane mucins (MUC1, MUC4, MUC16) form the glycocalyx, transforming the intrinsically hydrophobic epithelial cell membrane into an ultra-hydrophilic surface.
   • Dispersed throughout the aqueous liquid are soluble gel-forming mucins (MUC5AC, secreted by goblet cells) and soluble monomeric mucins (MUC7), co-existing with crucial electrolytes, antibacterial enzymes (lysozyme, lactoferrin), immunoglobulins (secretory IgA), and trophic peptide growth factors (epidermal growth factor, nerve growth factor).

---

Clinical Battery for Tear Film Dynamics

A rigorous diagnostic battery differentiates aqueous-deficient dry eye (ADDE) from evaporative dry eye (EDE), determining whether a patient requires medical pre-treatment or therapeutic lens intervention.

+------------------------------------------------------------------------------------------+
|                              TEAR FILM DIAGNOSTIC BATTERY                                |
+-------------------------+--------------------------------+-------------------------------+
| Test Parameter          | Normative Standard             | Pathological Diagnostic Cutoff|
+-------------------------+--------------------------------+-------------------------------+
| Fluorescein TBUT (FBUT) | > 10 seconds                   | < 5 seconds (Severe EDE)      |
| Non-Invasive TBUT       | First break > 10 s; avg > 14 s | < 10 seconds                  |
| Schirmer I (no anesth.) | > 15 mm in 5 minutes           | < 5 mm in 5 min (Severe ADDE) |
| Schirmer I (with anesth)| > 10 mm in 5 minutes           | < 5 mm in 5 minutes           |
| Schirmer II (nasal st.) | > 15 mm in 5 minutes           | < 15 mm (Reflex arc failure)  |
| Tear Meniscus Ht. (TMH) | ≥ 0.20 mm                      | < 0.18 mm (Volume depletion)  |
| Tear Osmolarity         | 290–300 mOsm/L                 | > 308 mOsm/L (or Δ > 8 mOsm/L)|
+-------------------------+--------------------------------+-------------------------------+

1. Tear Break-Up Time (TBUT & NITBUT)

• Fluorescein Tear Break-Up Time (TBUT / FBUT):
  • Method: Instill $5\ \mu\text{L}$ of preservative-free sodium fluorescein or a minimally moistened diagnostic strip into the inferior conjunctival sac. The patient blinks three times and then holds the eyes open under broad cobalt blue slit illumination with a yellow barrier filter. The time elapsed between the last complete blink and the appearance of the first black, non-fluorescent dry spot or fissure in the green tear film is timed in seconds.
  • Interpretation: Normal $>10\text{ s}$; Borderline $5\text{--}10\text{ s}$; Abnormal $<5\text{ s}$ (signifies severe tear film instability, typically driven by meibomian gland dysfunction or severe goblet cell mucin depletion).
• Non-Invasive Tear Break-Up Time (NITBUT):
  • Evaluated using automated Placido ring projection reflection or videokeratoscopy. It measures the breakup of the specular mire reflection without instilling liquid dyes.
  • Clinical Advantage: Instilling liquid fluorescein alters tear film volume, lowers surface tension, and induces hyperosmolar reflex tearing. NITBUT eliminates these diagnostic artifacts.

2. The Schirmer Diagnostic Battery

• Schirmer I Test (Without Anesthesia):
  • Measures total tear production—combining basal tear secretion and trigeminal reflex tearing.
  • A standardized sterile Whatman #41 filter paper strip ($5\times 35\text{ mm}$) is folded $5\text{ mm}$ at the notch and placed over the lower eyelid margin at the junction of the middle and lateral thirds, avoiding corneal contact. The patient rests with eyes gently closed in a dimly lit room for 5 minutes.
  • Interpretation: Normal $>15\text{ mm}$; Borderline $6\text{--}14\text{ mm}$; Severe aqueous deficiency $<5\text{ mm}$.
• Schirmer I Test (With Topical Anesthesia):
  • One drop of $0.5%$ proparacaine is instilled, and excess anesthetic is carefully blotted from the inferior fornix prior to strip insertion.
  • Eliminates sensory reflex afferents from the ocular surface to isolate resting basal secretion.
  • Interpretation: Wetting $<5\text{ mm}$ in 5 minutes confirms intrinsic basal lacrimal hyposecretion.
• Schirmer II Test (Reflex Secretion):
  • Performed with topical anesthesia. A cotton-tipped applicator is used to mechanically irritate the nasal mucosa at the middle turbinate, stimulating the ethmoidal branch of Cranial Nerve V.
  • Evaluates the capacity of the efferent secretomotor fibers (parasympathetic branch of Cranial Nerve VII) to stimulate the lacrimal gland. Wetting $<15\text{ mm}$ indicates failure of the secretomotor reflex or severe glandular parenchymal atrophy.

3. Tear Meniscus Height (TMH) & Tear Osmolarity

• Tear Meniscus Height (TMH): Evaluated at the lower eyelid margin directly inferior to the pupil center using a slit-lamp graticule or anterior segment OCT. Normal TMH is $\ge 0.20\text{ mm}$. A TMH $<0.18\text{ mm}$ signals aqueous volume reduction, and $<0.10\text{ mm}$ indicates profound aqueous deficiency.
• Tear Osmolarity: Measured via nanoliter electrical impedance sampling from the inferior lateral tear lake. Normal values range from $290\text{ to }300\text{ mOsm/L}$. An absolute reading $>308\text{ mOsm/L}$ in either eye, or an inter-eye difference $>8\text{ mOsm/L}$, supports tear-film homeostatic instability when interpreted with symptoms and other signs.

---

Severe Ocular Surface Diseases (OSD) in Specialty Practice

When medical therapies (preservative-free lubricants, topical cyclosporine/lifitegrast, punctal occlusion, autologous serum tears) fail to halt ocular surface breakdown, specialty lenses—most notably therapeutic scleral lenses—serve as a medical device to salvage vision and preserve ocular anatomy.

1. Sjögren's Syndrome

• Etiology: Systemic autoimmune exocrinopathy characterized by lymphocytic infiltration and progressive destruction of the lacrimal and salivary glands.
• Ocular Manifestations: Profound aqueous tear deficiency, severe filamentary keratitis, recurrent epithelial erosions, and increased risk of sterile corneal ulceration and perforation.

2. Ocular Graft-versus-Host Disease (oGVHD)

• Etiology: A frequent, severe complication occurring in $40%\text{--}60%$ of patients following allogeneic hematopoietic stem cell transplantation (HSCT). Donor-derived T lymphocytes mount an immunological attack against host antigens.
• Ocular Manifestations: Rapid-onset cicatricial conjunctivitis, dense lacrimal gland periductal fibrosis, severe meibomian gland ductal obliteration, symblepharon, pseudomembrane formation, and persistent epithelial defects (PEDs).

3. Stevens-Johnson Syndrome (SJS) & Toxic Epidermal Necrolysis (TEN)

• Etiology: Acute, life-threatening cell-mediated hypersensitivity reaction usually triggered by medications (e.g., sulfonamides, anticonvulsants, NSAIDs, allopurinol). Causes widespread keratinocyte apoptosis and sloughing of mucosal membranes.
• Ocular Sequelae: Destruction of conjunctival goblet cells, cicatricial entropion, trichiasis, keratinization of the eyelid margins and palpebral conjunctiva, symblepharon, and total limbal stem cell deficiency (LSCD). Blinking drives keratinized lids across the bare cornea like sandpaper.

4. Neurotrophic Keratitis (Cranial Nerve V Deficit)

• Etiology: Impairment of trigeminal corneal sensory innervation (Cranial Nerve V, ophthalmic division $V_1$). Causes include herpes simplex keratitis, herpes zoster ophthalmicus, acoustic neuroma resection, neurosurgical trauma, or longstanding diabetes mellitus.
• Pathophysiology: Corneal sensation provides vital trophic support; loss of sensory feedback deprives the cornea of substance P and nerve growth factor (NGF), leading to reduced epithelial mitosis, delayed wound healing, and decreased blink frequency.
• Mackie Staging:
  • Stage 1: Epithelial irregularity, punctate keratopathy, and stromal clouding.
  • Stage 2: Persistent Epithelial Defect (PED), typically oval with thickened, smooth, rolled epithelial edges.
  • Stage 3: Corneal stromal melting, necrosis, and perforation.

5. Exposure Keratopathy (Cranial Nerve VII Palsy)

• Etiology: Paresis or paralysis of the orbicularis oculi muscle driven by Facial Nerve (CN VII) deficits (e.g., Bell's palsy, acoustic neuroma resection, trauma) or anatomical lagophthalmos from thyroid eye disease (proptosis) or cicatricial lid retraction.
• Ocular Manifestations: Inability to achieve complete eyelid closure leads to chronic nocturnal evaporative desiccation, primarily concentrated across the inferior third of the cornea, causing deep ulceration and perforation.

---

Therapeutic Mechanisms of Scleral Lenses in OSD

Therapeutic scleral lenses act as a prosthetic ocular surface environment through three core biophysical mechanisms:

[Therapeutic Scleral Lens Functions in Severe OSD]
  ├── 1. Continuous Liquid Reservoir (150–350 µm unpreserved fluid)
  │      └── Bathes cornea 14–16 hrs/day; supports continuous epithelial hydration
  ├── 2. Mechanical Shielding
  │      └── Vaults cornea completely; insulates from lid shear, keratin, & trichiasis
  └── 3. Epithelial Regeneration & Pain Relief
         └── Accelerates PED healing; neutralizes irregular astigmatism

1. Continuous Corneal Liquid Reservoir: Scleral lenses vault completely over the cornea and limbus, resting entirely on the bulbar conjunctiva/sclera. The space between the posterior lens surface and the anterior cornea is filled with non-preserved physiological saline, creating a continuous, sealed liquid reservoir of $150\text{--}350\ \mu\text{m}$. This reservoir keeps the corneal epithelium perpetually submerged in fluid, preventing desiccation regardless of blink rate, tear volume, or environmental humidity.
2. Mechanical Shielding: The rigid lens barrier physically insulates the fragile, regenerating corneal epithelium from the abrasive shearing forces of blinking eyelids, keratinized palpebral margins, and misdirected eyelashes (trichiasis).
3. Promotion of Epithelial Regeneration & Visual Rehabilitation: By maintaining hydration and eliminating friction, scleral lenses promote rapid closure of chronic persistent epithelial defects (PEDs) that have resisted conventional medical intervention. Concurrently, the fluid reservoir neutralizes irregular corneal astigmatism, restoring clear functional vision and providing dramatic relief from debilitating photophobia and ocular pain.